ClinicalTrialsFinder

HPV Positive Oropharyngeal Squamous Cell Carcinoma Clinical Trials in Baltimore, Maryland

1 recruitingBaltimore, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
University of Maryland, Baltimore61 enrolled5 locationsNCT06088381